Catherine Yuan

Huazhong University of Science and Technology — China

Medicine · Health Sciences

11h-index1.5kcitations25works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell Adhesion Molecules Research(5), Chemical Synthesis and Analysis(5), Receptor Mechanisms and Signaling(4), Protease and Inhibitor Mechanisms(3), Antimicrobial Peptides and Activities(3)

Publications25 total

Current Landscape of Hydroxamic Acid Derivatives With Antileukemia Activity
Archiv der Pharmazie·2025
Training the Next Generation of Seismologists: Delivering Research-Grade Software Education for Cloud and HPC Computing through Diverse Training Modalities
arXiv (Cornell University)·2024Open Access
Demonstration of a Software Solution to Support OpenConfig and OpenROADM
2019· 3 cited
Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9<i>R</i>)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe Pain
Journal of Medicinal Chemistry·2013· 193 citedOpen Access
Sphenostylisins A-K, NF-κB Inhibitors, Quinone Reductase Inducers, and Antioxidants from Sphenostylis marginata ssp. erecta
Planta Medica·2013· 1 cited
A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine
Journal of Pharmacology and Experimental Therapeutics·2013· 631 cited
Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles
Bioorganic & Medicinal Chemistry Letters·2008· 8 citedOpen Access
Development of potent and selective small-molecule human Urotensin-II antagonists
Bioorganic & Medicinal Chemistry Letters·2008· 8 citedOpen Access
CCDC 186477: Experimental Crystal Structure Determination
The Cambridge Structural Database·2005Open Access
Hakuin, le secret de la contemplation : vie et enseignements d'un maître zen
Dervy eBooks·2004
Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonists
Bioorganic & Medicinal Chemistry Letters·2003· 27 citedOpen Access
Ryokan : le chemin vide : vie et poèmes d'un moine zen
Dervy eBooks·2003
Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents
Antimicrobial Agents and Chemotherapy·2002· 163 citedOpen Access
Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI)
Journal of Medicinal Chemistry·2002· 109 citedOpen Access
DISCOVERY OF AMINOPYRIDINE-BASED INHIBITIORS OF BACTERIAL ENOYL-ACP REDUCTASE (FABI)
Molecular Cell·2002
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)
Bioorganic & Medicinal Chemistry Letters·2001· 124 citedOpen Access
Regioselective alkylation at the N4 positionof a 3-oxo-1,4-benzodiazepine on solid support
Molecular Diversity·2000· 7 cited
Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic
Journal of Medicinal Chemistry·1999· 116 citedOpen Access
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics
Bioorganic & Medicinal Chemistry Letters·1999· 30 citedOpen Access
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonist with efficacy in a restenosis model
Bioorganic & Medicinal Chemistry Letters·1998· 21 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Irene N. Uzinskas(9), William F. Huffman(9), William H. Miller(8), Dirk A. Heerding(7), Dennis T. Takata(7), Chet Kwon(7), Shing‐Mei Hwang(7), William E. Bondinell(6), Karl F. Erhard(6), Russell D. Cousins(5), Richard M. Keenan(5), James M. Samanen(5), David J. Rieman(5), Brian R. Smith(5), Fadia E. Ali(5), Michael W. Lark(4), Peter J. Manley(4), Kenneth A. Newlander(4), Kevin L. Salyers(4), R. Curtis Haltiwanger(4)